Skip to main content
Top
Published in: Clinical Rheumatology 7/2017

Open Access 01-07-2017 | Original Article

Seasonal variations of urate in a Swedish adult population

Authors: Axel Åkerblom, Johanna Helmersson-Karlqvist, Tomas Weitoft, Anders Larsson

Published in: Clinical Rheumatology | Issue 7/2017

Login to get access

Abstract

Seasonality in the incidence and prevalence of gout has previously been reported but the cause of this seasonality in gout is not explained. The aim of this study was to evaluate possible seasonal variations of urate in a large unselected Swedish adult population. We analyzed 170,915 urate test results from patients at a tertiary care hospital between 2000 and 2016. The results were divided according to sex and sampling month of the year. The median urate values were overall higher in males compared to females and both males and females had peak urate concentrations in the summer months (June–August). There is a seasonal pattern for urate concentrations in a large Swedish population similar to the previously reported seasonality for gout. This may be clinically important and could contribute to the circannual variation of gout. The seasonal pattern should be recognized when evaluating patient results both in clinical practice and in research studies.
Literature
1.
go back to reference Juraschek SP, Miller ER III, Gelber AC (2013) Body mass index, obesity, and prevalent gout in the United States in 1988-1994 and 2007-2010. Arthritis Care Res (Hoboken ) 65:127–132CrossRef Juraschek SP, Miller ER III, Gelber AC (2013) Body mass index, obesity, and prevalent gout in the United States in 1988-1994 and 2007-2010. Arthritis Care Res (Hoboken ) 65:127–132CrossRef
3.
go back to reference Khanna PP, Fitzgerald J (2015) Evolution of management of gout: a comparison of recent guidelines. Curr Opin Rheumatol 27:139–146CrossRefPubMed Khanna PP, Fitzgerald J (2015) Evolution of management of gout: a comparison of recent guidelines. Curr Opin Rheumatol 27:139–146CrossRefPubMed
4.
go back to reference Conway R, Coughlan RJ, Carey JJ (2012) Adherence to uric acid treatment guidelines in a rheumatology clinic. Clin Rheumatol 31:1707–1711CrossRefPubMed Conway R, Coughlan RJ, Carey JJ (2012) Adherence to uric acid treatment guidelines in a rheumatology clinic. Clin Rheumatol 31:1707–1711CrossRefPubMed
5.
go back to reference Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda-Sanabria J, et al (2016) updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 2016 Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda-Sanabria J, et al (2016) updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 2016
6.
go back to reference MacFarlane LA, Kim SC (2014) Gout: a review of nonmodifiable and modifiable risk factors. Rheum Dis Clin N Am 40:581–604CrossRef MacFarlane LA, Kim SC (2014) Gout: a review of nonmodifiable and modifiable risk factors. Rheum Dis Clin N Am 40:581–604CrossRef
8.
go back to reference Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11:649–662CrossRefPubMed Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11:649–662CrossRefPubMed
10.
go back to reference Xu C (2016) Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back. Hepatol Int 10:286–293CrossRefPubMed Xu C (2016) Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back. Hepatol Int 10:286–293CrossRefPubMed
11.
go back to reference Hainer BL, Matheson E, Wilkes RT (2014) Diagnosis, treatment, and prevention of gout. Am Fam Physician 90:831–836PubMed Hainer BL, Matheson E, Wilkes RT (2014) Diagnosis, treatment, and prevention of gout. Am Fam Physician 90:831–836PubMed
13.
go back to reference Zhang C, Fan K, Luo H, Ma X, Liu R, Yang L et al (2012) Characterization, efficacy, pharmacokinetics, and biodistribution of 5kDa mPEG modified tetrameric canine uricase variant. Int J Pharm 430:307–317CrossRefPubMed Zhang C, Fan K, Luo H, Ma X, Liu R, Yang L et al (2012) Characterization, efficacy, pharmacokinetics, and biodistribution of 5kDa mPEG modified tetrameric canine uricase variant. Int J Pharm 430:307–317CrossRefPubMed
14.
go back to reference Becker MA (1988) Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout). Rheum Dis Clin N Am 14:377–394 Becker MA (1988) Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout). Rheum Dis Clin N Am 14:377–394
16.
17.
go back to reference Elliot AJ, Cross KW, Fleming DM (2009) Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994-2007. Ann Rheum Dis 68:1728–1733CrossRefPubMed Elliot AJ, Cross KW, Fleming DM (2009) Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994-2007. Ann Rheum Dis 68:1728–1733CrossRefPubMed
18.
go back to reference Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T et al (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 67:960–966CrossRefPubMed Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T et al (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 67:960–966CrossRefPubMed
19.
go back to reference Borghi C, Perez-Ruiz F (2016) Urate lowering therapies in the treatment of gout: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 20:983–992PubMed Borghi C, Perez-Ruiz F (2016) Urate lowering therapies in the treatment of gout: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 20:983–992PubMed
20.
go back to reference Andersson I, Rossner S (1992) The Christmas factor in obesity therapy. Int J Obes Relat Metab Disord 16:1013–1015PubMed Andersson I, Rossner S (1992) The Christmas factor in obesity therapy. Int J Obes Relat Metab Disord 16:1013–1015PubMed
21.
go back to reference Carran EL, White SJ, Reynolds AN, Haszard JJ, Venn BJ (2016) Acute effect of fructose intake from sugar-sweetened beverages on plasma uric acid: a randomised controlled trial. Eur J Clin Nutr 70:1034–1038CrossRefPubMed Carran EL, White SJ, Reynolds AN, Haszard JJ, Venn BJ (2016) Acute effect of fructose intake from sugar-sweetened beverages on plasma uric acid: a randomised controlled trial. Eur J Clin Nutr 70:1034–1038CrossRefPubMed
22.
go back to reference Karmacharya P, Pathak R, Aryal MR, Giri S, Donato AA (2016) Seasonal variation in acute gouty arthritis: data from nationwide inpatient sample. Clin Rheumatol 35:523–525CrossRefPubMed Karmacharya P, Pathak R, Aryal MR, Giri S, Donato AA (2016) Seasonal variation in acute gouty arthritis: data from nationwide inpatient sample. Clin Rheumatol 35:523–525CrossRefPubMed
Metadata
Title
Seasonal variations of urate in a Swedish adult population
Authors
Axel Åkerblom
Johanna Helmersson-Karlqvist
Tomas Weitoft
Anders Larsson
Publication date
01-07-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 7/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3591-z

Other articles of this Issue 7/2017

Clinical Rheumatology 7/2017 Go to the issue